Perlegen perlegen.com


Public lists: Pharma Startups (4732)

Perlegen Sciences, Inc. uses high-density, whole-wafer microarray technology in combination with new approaches to sample preparation to scan entire human genomes. The company's first objective was to read 50 different human genomes at a single base resolution, discovering and analyzing the patterns of genetic variation between them.

Perlegen Sciences, Inc. uses high-density, whole-wafer microarray technology in combination with new approaches to sample preparation to scan entire human genomes. The company's first objective was to read 50 different human genomes at a single base ...Show all

Company (Acquired)

Phone: 650-625-4500

Fax:

2021 Stierlin Court

Mountain View, 94043
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Perlegen $119M Apr 15, 2010
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Perlegen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Signature Genomic Laboratories

Spokane, Washington, United States
Alive / ActiveSignature Genomic Laboratories aims to use microarray technology to help diagnose chromosome abnormal disabilities in children with developmental disabilitiesLogin to see details

Axela Biosensors

Toronto, Ontario, Canada
Alive / ActiveAxela is delivering on its mission to provide a simple and effective approach to personalized medicine by exploiting the dotLab System in research markets today to generate tomorrow's diagnostics. This strategy of offering a common technology platform to both markets aims to provide a opportunity to capitalize on discoveries. The approach has already resulted in applications with the potential to address segments of the large, underserved markets of oncology and cardiology that will be the focus...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)